POC Analyzers (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 market impact)
|POC分析設備:體外診斷市場分析及預測模式 POC Analyzers (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 market impact)|
|出版日期: 2020年08月30日||內容資訊: 英文||
POC Analyzers (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area.
The model discusses in detail the impact of COVID-19 on POC Analyzers market for the year 2020 and beyond. The need for rapidity of results for immediate and effective clinical intervention, and recent technological advances and the fact that it is not always feasible for physicians and patients living in rural areas to have access to 24-hour clinical laboratory services are the major reasons for the development of POC Analyzers. POC Analyzers market is segmented into POC PCR Systems, POC Immunochemistry Analyzers and POC Hand-held Hematology Analyzers.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed POC Analyzers and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered - Abbott Laboratories, F. Hoffmann-La Roche Ltd, Danaher Corp, EKF Diagnostics Holdings Plc, Siemens Healthineers AG, and Others
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
Who should buy this report?
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -